INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 62,847 Value ($000) $1,165 Avg Close — Range —
Q4 2020
Shares 13,830 Value ($000) $342 Avg Close — Range —
Q3 2019
Shares 151 Value ($000) $10 Avg Close — Range —
Q2 2019
Shares 154 Value ($000) $12 Avg Close — Range —
Q1 2019
Shares 174 Value ($000) $19 Avg Close — Range —
Q4 2018
Shares 73 Value ($000) $7 Avg Close — Range —
Q3 2018
Shares 73 Value ($000) $9 Avg Close — Range —
Q2 2018
Shares 13,143 Value ($000) $1,103 Avg Close — Range —
Q3 2017
Shares 1,754 Value ($000) $102 Avg Close — Range —
Q2 2017
Shares 17,567 Value ($000) $2,127 Avg Close — Range —
Q1 2017
Shares 1,460 Value ($000) $165 Avg Close — Range —